Results 211 to 220 of about 105,016 (295)
FAT1-associated membranous nephropathy after hematopoietic stem cell transplantation: a case report and review of the literature. [PDF]
Saiki R +4 more
europepmc +1 more source
Aberrant GALNT7‐mediated O‐GalNAcylation stabilizes TAZ to drive gallbladder cancer progression through a feed‐forward transcriptional loop. Structure‐based screening identifies Olaparib as a potent GALNT7 antagonist that disrupts this oncogenic axis, providing an immediate therapeutic strategy for this aggressive malignancy.
Peng Qiu +11 more
wiley +1 more source
Concurrent Mantle Cell Lymphoma and Paraneoplastic Membranous Nephropathy. [PDF]
Lv D +7 more
europepmc +1 more source
Lipid nanostructured particles with increasing negative Gaussian curvature progress from vesicles to P‐cubosomes and D‐cubosomes. This curvature hierarchy enhances interaction with bacterial membranes, promotes membrane remodeling and leakage, and potentiates daptomycin activity against MRSA.
Xiangfeng Lai +10 more
wiley +1 more source
Optimization of a Target Antigen Diagnostic Pathway for Membranous Nephropathy. [PDF]
Li W +15 more
europepmc +1 more source
In diabetic kidney disease, elevated podocyte ANGPTL4 is linked to reduced TFEB nuclear localization and compromised lysosomal degradative function. These changes impair podocyte lipophagy and promote lipid‐droplet accumulation and podocyte injury, which may contribute to renal injury progression.
Xiaojing Liu +7 more
wiley +1 more source
Animal models of idiopathic membranous nephropathy: Recent advances and future perspectives. [PDF]
Liu Q +6 more
europepmc +1 more source
CFP/PC@MnO2 hydrogel integrates ROS scavenging, oxygen delivery, oxidative stress reduction, immunomodulation, and photothermal antibacterial properties. The incorporation of PC@MnO2 NPs endows the hydrogel with multiple functional advantages tailored to the pathological microenvironment of diabetic wounds, including efficient ROS clearance, mitigation
Zhi Xu +9 more
wiley +1 more source
Efficacy and safety of obinutuzumab in refractory membranous nephropathy: a single-arm meta-analysis. [PDF]
Cong P, Wang J, Du X.
europepmc +1 more source

